Literature DB >> 24715932

Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population.

Khalid Al-Rasadi1, Khalid Al-Waili1, Hilal Ali Al-Sabti2, Ali Al-Hinai3, Khamis Al-Hashmi3, Ibrahim Al-Zakwani4, Yajnavalka Banerjee1.   

Abstract

Subjects with Familial hypercholesterolemia are at increased risk for cardiac events such as premature myocardial infarction and early death from coronary heart disease, especially in patients with severe forms of the disease if left unattended. Therefore, there is an ardent need for the early diagnosis followed by aggressive therapeutic intervention and lifestyle modification. Three groups have developed clinical diagnostic tools for Familial hypercholesterolemia: the US MedPed Program, the Simon Broome Register Group in the United Kingdom, and the Dutch Lipid Clinic Network. In this article, the individual criteria are reviewed with particular emphasis on their advantage(s) and disadvantage(s), and in turn assess their suitability in diagnosing Familial hypercholesterolemia in the Omani Arab population. A brief insight into the process of "Cascade Screening" is also provided, this is a procedure that we are in the process of establishing in Oman.

Entities:  

Keywords:  Cascade-Screening; Dutch Criteria; Familial hypercholesterolemia; Omani Arab Population; Simon-Broome Criteria; US-Medped Criteria

Year:  2014        PMID: 24715932      PMCID: PMC3976735          DOI: 10.5001/omj.2014.22

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  34 in total

1.  Medical informatics and health care in Oman.

Authors:  A Dhar
Journal:  J Am Med Inform Assoc       Date:  2001 Sep-Oct       Impact factor: 4.497

Review 2.  Monogenic hypercholesterolemia: new insights in pathogenesis and treatment.

Authors:  Daniel J Rader; Jonathan Cohen; Helen H Hobbs
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

3.  Familial hypercholesterolaemia: summary of NICE guidance.

Authors:  Anthony S Wierzbicki; Steve E Humphries; Rubin Minhas
Journal:  BMJ       Date:  2008-08-27

4.  Treatment beliefs and attending follow-up visits in a lipid clinic.

Authors:  Avishay Elis; Michael Lishner; Samuel Melamed
Journal:  Br J Health Psychol       Date:  2011-02

Review 5.  Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.

Authors:  George Yuan; Jian Wang; Robert A Hegele
Journal:  CMAJ       Date:  2006-04-11       Impact factor: 8.262

Review 6.  Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program.

Authors:  Trond P Leren; Turid Manshaus; Unn Skovholt; Tove Skodje; Inger Esther Nossen; Christél Teie; Stine Sørensen; Kari Solberg Bakken
Journal:  Semin Vasc Med       Date:  2004-02

7.  Homozygous familial hypercholesterolemia among French Canadians in Québec Province.

Authors:  S Moorjani; M Roy; C Gagné; J Davignon; D Brun; M Toussaint; M Lambert; L Campeau; S Blaichman; P Lupien
Journal:  Arteriosclerosis       Date:  1989 Mar-Apr

8.  Targeted capture and massively parallel sequencing of 12 human exomes.

Authors:  Sarah B Ng; Emily H Turner; Peggy D Robertson; Steven D Flygare; Abigail W Bigham; Choli Lee; Tristan Shaffer; Michelle Wong; Arindam Bhattacharjee; Evan E Eichler; Michael Bamshad; Deborah A Nickerson; Jay Shendure
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

9.  Exome sequencing of a patient with suspected mitochondrial disease reveals a likely multigenic etiology.

Authors:  William J Craigen; Brett H Graham; Lee-Jun Wong; Fernando Scaglia; Richard Alan Lewis; Penelope E Bonnen
Journal:  BMC Med Genet       Date:  2013-08-16       Impact factor: 2.103

Review 10.  Current management of severe homozygous hypercholesterolaemias.

Authors:  Rossi P Naoumova; Gilbert R Thompson; Anne K Soutar
Journal:  Curr Opin Lipidol       Date:  2004-08       Impact factor: 4.776

View more
  12 in total

1.  Dyslipidemia in the Arabian Gulf and its Impact on Cardiovascular Risk Outcome.

Authors:  Khalid Al-Rasadi; Hilal Al-Sabti
Journal:  Oman Med J       Date:  2015-11

Review 2.  Exploring the Efficacy of Alirocumab and Evolocumab in Reducing Low-Density Lipoprotein (LDL) Cholesterol Levels in Patients With Familial Hypercholesterolemia: A Systematic Review.

Authors:  Gaurav Luthra; Mahrukh Shahbaz; Halah Almatooq; Paul Foucambert; Faith Esbrand; Sana Zafar; Venkatesh Panthangi; Adrienne R Cyril Kurupp; Anjumol Raju; Safeera Khan
Journal:  Cureus       Date:  2022-09-08

Review 3.  Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices.

Authors:  Nuntakorn Thongtang; Renan Sukmawan; Elmer Jasper B Llanes; Zhen-Vin Lee
Journal:  Prev Med Rep       Date:  2022-05-05

4.  Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum.

Authors:  Hossein Kavoussi; Ali Ebrahimi; Mansour Rezaei; Mazaher Ramezani; Behnaz Najafi; Reza Kavoussi
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

5.  Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel.

Authors:  Abdullah Al-Ashwal; Fahad Alnouri; Hani Sabbour; Abdulraof Al-Mahfouz; Nasreen Al-Sayed; Maryam Razzaghy-Azar; Faisal Al-Allaf; Khalid Al-Waili; Yajnavalka Banerjee; Jacques Genest; Raul D Santos; Khalid Al-Rasadi
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

Review 6.  The genetics and screening of familial hypercholesterolaemia.

Authors:  Raymond Henderson; Maurice O'Kane; Victoria McGilligan; Steven Watterson
Journal:  J Biomed Sci       Date:  2016-04-16       Impact factor: 8.410

7.  The tertiary hospital laboratory; a novel avenue of opportunistic screening of familial hypercholesterolemia.

Authors:  Sam Mirzaee; Kay W Choy; James C G Doery; Sarah Zaman; James D Cameron; Arthur Nasis
Journal:  Int J Cardiol Heart Vasc       Date:  2019-05-03

8.  Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.

Authors:  Thuhairah Rahman; Nur Suhana Hamzan; Atiqah Mokhsin; Radzi Rahmat; Zubin Othman Ibrahim; Rafezah Razali; Malathi Thevarajah; Hapizah Nawawi
Journal:  Lipids Health Dis       Date:  2017-04-24       Impact factor: 3.876

9.  Familial Hypercholesterolemia: A Systematic Review of Guidelines on Genetic Testing and Patient Management.

Authors:  Giuseppe Migliara; Valentina Baccolini; Annalisa Rosso; Elvira D'Andrea; Azzurra Massimi; Paolo Villari; Corrado De Vito
Journal:  Front Public Health       Date:  2017-09-25

Review 10.  Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?

Authors:  Lakshmi Lavanya Reddy; Swarup A V Shah; Tester F Ashavaid
Journal:  Indian Heart J       Date:  2021-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.